Newlink Genetics (NLNK) Reports In-Line Q2 Loss of 31c/Share; Reaffirms Outlook
Tweet Send to a Friend
Newlink Genetics (NASDAQ: NLNK) reported Q2 EPS of ($0.31), in-line ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
